Arcosa, Inc. ACA 深 滬
等待開盤 04-01 09:30:00 美东时间
106.14
+4.050
+3.97%
華盛通- 最 高107.005
- 今 開104.07
- 成交量 25.94万股
- 最 低 102.4175
- 昨 收 102.09
- 總市值 52.06亿
- 52周最高 131.00
- 市盈率 靜 25.00
- 換手率 0.53%
- 52周最低 73.78
- 委 比 0.00%
- 總股本 4904.40万
- 歷史最高 131.00
- 量 比 0.85
- 振 幅 4.49%
- 歷史最低 21.49
- 每 手 1
- 風險率 12.76%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 花旗：维持康菲石油"买入"评级！目标价从125美元升至135美元
今日重点评级关注：HC Wainwright & Co.：维持Helus Pharma"买入"评级，目标价从55美元升至95美元；HC Wainwright & Co.：维持Compass Pathways"买入"评级，目标价从40美元升至70美元
03-03 20:22
DA Davidson Maintains Buy on Arcosa, Raises Price Target to $125
DA Davidson analyst Brent Thielman maintains Arcosa (NYSE:ACA) with a Buy and raises the price target from $120 to $125.
03-03 03:58
Arcosa shares are trading lower after the company reported Q4 sales below estimates.
Arcosa shares are trading lower after the company reported Q4 sales below estim...
02-28 03:35
财报速睇 | Arcosa, Inc. 2025财年年度营收28.83亿美元，同比增长12.2%；归母净利润2.08亿美元，同比增长121.3%
华盛资讯2月28日讯，Arcosa, Inc.公布2025财年年度业绩，公司年度营收28.83亿美元，同比增长12.2%，归母净利润2.08亿美元，同比增长121.3%。
02-28 00:17
Earnings Scheduled For February 26, 2026
Companies Reporting Before The Bell • Enovis (NYSE:ENOV) is estimated to report...
02-26 19:11
Arcosa declares $0.05 dividend
Arcosa (ACA) declares $0.05/share quarterly dividend, in line with previous. Forward yield 0.18% Payable Jan. 30; for shareholders of record Jan. 15; ex-div Jan. 15. See ACA Dividend Scorecard, Yield ...
2025-12-12 12:41
Argan's Earnings: A Preview
Argan (NYSE:AGX) is set to give its latest quarterly earnings report on Thursda...
2025-12-03 23:01
What to Expect from Construction Partners's Earnings
Construction Partners (NASDAQ:ROAD) is set to give its latest quarterly earning...
2025-11-19 23:02
Arcosa Updates Investor Presentation on Strategic Moves
Arcosa ( ($ACA) ) has shared an announcement. Arcosa, Inc. has updated its inve...
2025-11-11 05:52
美股大行评级 | 高盛上调英伟达目标价升至240美元； Loop Capital上调英伟达目标价升至350美元！
今日重点评级关注：花旗：维持Caribou Biosciences"买入"评级，目标价从5美元升至8美元；HC Wainwright & Co.：上调MoonLake Immunotherapeutics - Class A Ordinary Shares评级至"买入"，目标价30美元
2025-11-04 10:31
